Showing 1-10 of 1044 results for "".
Neuroimmune Parallels in Atopic Dermatitis and Prurigo Nodularis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/neuroimmune-parallels-in-atopic-dermatitis-and-prurigo-nodularis/39667/JAK Inhibitors in Hidradenitis Suppurativa: A Systematic Review
https://practicaldermatology.com/topics/feature/jak-inhibitors-in-hidradenitis-suppurativa-a-systematic-review/29887/Hidradenitis suppurativa (HS) is a chronic, disfiguring, debilitating, inflammatory disorder that is characterized by inflammatory nodules, abscesses, fistulae/ sinus tracts, and scarring to the axilla, inframammary folds, and groin.Busy by Design Plans: How to Use Downtime to Drive Revenue and Make Uptime Smoother for Your Team
https://practicaldermatology.com/issues/september-2025/busy-by-design-plans-how-to-use-downtime-to-drive-revenue-and-make-uptime-smoother-for-your-team/37641/In today’s fast-paced dermatology industry, treatments can sometimes feel more transactional than transformational.- Jonathan Nihttps://practicaldermatology.com/profiles/jonathan-ni/L6KQPE/
Jonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition
https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to uSignificant FDA Approval for PDT
https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.The Road to Denver – Targeting IL-31: A Case-Based Journey
https://practicaldermatology.com/series/nemluvio-peer-network/the-road-to-denver-targeting-il-31-a-case-based-journey/56419/Join Dr Raj Chovatiya, Dr Mona Shahriari, and Dr Jonathan Silverberg as they discuss Targeting the IL-31 Neuroimmune Pathway: A Case-Based Approach. This Product Theater will take place Sunday, March 29, 2026, from 10:30–11:15 AM MT at the Colorado Convention Center, Theater 1 in Denver, Colorado. PNickel Barrier Methods
https://practicaldermatology.com/topics/atopic-dermatitis/nickel-barrier-methods/20465/Do they affect instrument sound?NIH Analysis Examines Association Between AD and Comorbidities
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/nih-analysis-examines-association-between-ad-and-comorbidities/27113/In this week's DermwireTV, new NIH data looks at the association between AD and several health conditions; a study evaluates the effect of lebrikizumab monotherapy in patients with moderate-to-severe AD over 16 weeks; and Andrew Mastro provides tips on how to optimize the first 5 minutes with a patiLow-Nickel Diets Show Promise for Contact Dermatitis
https://practicaldermatology.com/conferences/maui-derm-2024/low-nickel-diets-show-promise-for-contact-dermatitis/20256/Matthew Zirwas, MD, discusses his experience with the “low-nickel diet” for patients who have systemic reactions to dietary nickel.
- Prev
- Next